|
Re: Where is the trial?
|
5
|
Resverlogix Corp.
|
Apr 23, 2021 06:09PM
|
|
Re: Can big pharma afford Apabetalone?
|
5
|
Resverlogix Corp.
|
Jun 18, 2018 12:23PM
|
|
Re: Wonder what the big investors think currently
|
5
|
Resverlogix Corp.
|
Dec 02, 2023 07:51PM
|
|
Re: News from a Chinese/Japenese Article about Zenith
|
5
|
Zenith Epigenetics
|
Oct 27, 2016 11:58AM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
5
|
Resverlogix Corp.
|
Apr 13, 2018 04:58PM
|
|
Re: AGM - High Level Summary
|
5
|
Zenith Epigenetics
|
Jan 12, 2016 08:25PM
|
|
RVX NPV
|
5
|
Resverlogix Corp.
|
Oct 07, 2016 11:24AM
|
|
Re: Quick question for the science folks
|
5
|
Resverlogix Corp.
|
Apr 03, 2021 03:27PM
|
|
Re: One Possibility: Zenith Takes The Prize
|
5
|
Resverlogix Corp.
|
Jun 13, 2017 05:20PM
|
|
Re: Gasoline
|
5
|
Zenith Epigenetics
|
Jan 31, 2017 10:52AM
|
|
Re: iceberg or ice cube?
|
5
|
Resverlogix Corp.
|
May 16, 2017 11:24AM
|
|
Re: Welcome to the party ABBV-744
|
5
|
Resverlogix Corp.
|
Feb 22, 2018 02:32PM
|
|
New PP on Aug 13
|
5
|
Zenith Epigenetics
|
Aug 19, 2019 11:07PM
|
|
Bio Europe slide deck
|
5
|
Zenith Epigenetics
|
Dec 06, 2018 02:16AM
|
|
Re: The CKD opportunity
|
5
|
Resverlogix Corp.
|
Jul 27, 2017 11:14AM
|
|
Re: AGM - High Level Summary
|
5
|
Zenith Epigenetics
|
Jan 12, 2016 10:14PM
|
|
Re: Zenith-Oncology Pipeline
|
5
|
Zenith Epigenetics
|
Mar 19, 2021 11:23AM
|
|
Re: Lilly alzheimer drug failed
|
5
|
Resverlogix Corp.
|
Nov 24, 2016 12:29PM
|
|
Re: What if...?
|
5
|
Zenith Epigenetics
|
Dec 12, 2015 12:38PM
|
|
Re: Reports of exempt distribution on SEDAR
|
5
|
Resverlogix Corp.
|
Mar 29, 2018 11:55AM
|
